← Back to Search

Interferon

Infergen for Influenza

Phase 1 & 2
Waitlist Available
Led By Dante Morra, MD, MBA
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to two-months post-treatment
Awards & highlights

Study Summary

A Pilot Study to Evaluate the Safety and Efficacy of interferon-Alfacon1 (INFERGEN) in the treatment of patients hospitalized with Influenza-like illness caused by a novel swine origin Influenza virus and other circulating Influenza Viruses. The use of Interferon-alfacon1 as a co-treatment along with the standard of care antiviral is hypothesized to be safe. Clinical improvement of patients is hypothesized to be quicker.

Eligible Conditions
  • Influenza

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to two-months post-treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to two-months post-treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Frequency of Clinically Important (moderate or severe) and serious adverse events
Secondary outcome measures
Clinical Improvement
Cytokines and PBMC
Virologic Clearance

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: InfergenActive Control1 Intervention
15mcg subcutaneous injection at fill volume of 0.5mL
Group II: PlaceboPlacebo Group1 Intervention
100 mM sodium Chloride and 25 mM sodium phosphate at pH 7.0 +/- 0.2

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,471 Previous Clinical Trials
484,940 Total Patients Enrolled
Dante Morra, MD, MBAPrincipal InvestigatorUniversity Health Network, Toronto

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for Influenza
2010. "Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for Influenza". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01227798.
All > Flu
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top